The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 28, 2021

Filed:

Sep. 26, 2018
Applicants:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA (US);

Inventors:

David Weiner, Merion, PA (US);

Karuppiah Muthumani, Cherry Hill, NJ (US);

Seleeke Flingai, Minneapolis, MN (US);

Niranjan Sardesai, Blue Bell, PA (US);

Assignees:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/10 (2006.01); C07K 16/32 (2006.01); A61K 31/7088 (2006.01); A61K 39/12 (2006.01); A61K 39/21 (2006.01); A61K 48/00 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01); A61M 37/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/1081 (2013.01); A61K 31/7088 (2013.01); A61K 39/12 (2013.01); A61K 39/21 (2013.01); A61K 48/00 (2013.01); C07K 16/10 (2013.01); C07K 16/1063 (2013.01); C07K 16/32 (2013.01); C12N 7/00 (2013.01); A61K 48/005 (2013.01); A61K 2039/505 (2013.01); A61K 2039/53 (2013.01); A61M 2037/0007 (2013.01); C07K 2317/10 (2013.01); C07K 2317/14 (2013.01); C07K 2317/21 (2013.01); C07K 2317/55 (2013.01); C07K 2317/60 (2013.01); C07K 2317/76 (2013.01); C12N 2740/16034 (2013.01); C12N 2740/16111 (2013.01); C12N 2740/16134 (2013.01); C12N 2770/24111 (2013.01); C12N 2770/24134 (2013.01); C12N 2770/36034 (2013.01); C12N 2770/36111 (2013.01); Y02A 50/30 (2018.01);
Abstract

Disclosed herein is a composition including a recombinant nucleic acid sequence that encodes an antibody. Also disclosed herein is a method of generating a synthetic antibody in a subject by administering the composition to the subject. The disclosure also provides a method of preventing and/or treating disease in a subject using said composition and method of generation.


Find Patent Forward Citations

Loading…